This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Les Laboratoires Servier. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Franziska Katharina Uhlenbrock: Innovator in Immunotherapy
Introduction
Franziska Katharina Uhlenbrock is a notable inventor based in Værløse, Denmark. She has made significant contributions to the field of immunotherapy, particularly through her work on anti-NKG2A antibodies. Her innovative approach aims to enhance immunity in patients and offers potential treatments for cancer.
Latest Patents
Uhlenbrock holds a patent for "Anti-NKG2A antibodies and compositions." This invention relates to the development of anti-NKG2A antibodies and methods for using them to improve immune responses in patients who require such interventions. The patent highlights her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Franziska Katharina Uhlenbrock has established herself as a key figure in her field. She is currently associated with Les Laboratoires Servier, where she continues to work on groundbreaking research and development projects. Her dedication to innovation is evident in her patent and ongoing contributions to immunotherapy.
Collaborations
Uhlenbrock collaborates with talented colleagues, including Randi Westh Hansen and Nikolaj Dietrich. These partnerships enhance her research efforts and contribute to the advancement of their shared goals in the medical field.
Conclusion
Franziska Katharina Uhlenbrock is a pioneering inventor whose work in anti-NKG2A antibodies represents a significant advancement in immunotherapy. Her contributions are poised to make a lasting impact on cancer treatment and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile